Autism

Rose Hill Life Sciences to Spotlight Leading Research Partners at Psychedelic Science 2025

Dr. Gül Dölen, MD, PhD, to share groundbreaking research on how psychedelic compounds can reopen “critical periods” of brain plasticity.…

7 months ago

Empowered with Meg Ryan and Youth Consultation Service Redefine Education for Diverse Learners

LOS ANGELES, June 10, 2025 /PRNewswire/ -- Public Television audiences are invited to discover a refreshing perspective on educational possibilities…

7 months ago

Access Ready Strategic Joins Leading Disability Organizations in Support of Critical Policy Positions

Collaborative Advocacy Responds to Swift Federal and State Policy Shifts WASHINGTON, May 8, 2025 /PRNewswire/ -- Access Ready Strategic, a national…

8 months ago

AnswersNow Named Best Telehealth Platform in 2025 MedTech Breakthrough Awards

Transformational virtual provider of autism therapy provides fast, convenient access to quality care for families everywhereRICHMOND, Va., May 08, 2025…

8 months ago

ATrack Solutions Named Business Affiliate of The Council of Autism Service Providers (CASP)

ST. AUGUSTINE, Fla., May 7, 2025 /PRNewswire/ -- ATrack Solutions, a leading provider of ABA-focused clinical and operational software, is proud…

8 months ago

NexPhase Announces Acquisition of Behavior Frontiers

Partnership to Support Company's Deeply Experienced Existing Leadership Team and Thoughtful Execution of Expansion Roadmap NEW YORK, May 5, 2025 /PRNewswire/…

8 months ago

Baijiayun Announces Plan to Invest Tens of Millions of Dollars Over Five Years to Build New Ecosystem for Autism Rehabilitation

BEIJING, April 25, 2025 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution…

8 months ago

Baijiayun Announces Plan to Invest Tens of Millions of Dollars Over Five Years to Build New Ecosystem for Autism Rehabilitation

BEIJING, April 25, 2025 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution…

8 months ago

ORYZON Raises €30 Million in Capital Increase

Issued 12,765,958 new sharesPriced at €2.35 per share, representing a 15.44% discount on the 5-day VWAPStrong investor demand, with the…

8 months ago

ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat

New “Decision to grant” communications in Europe and JapanMADRID and CAMBRIDGE, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics,…

8 months ago